No association between temozolomide maintenance and survival after first‐line treatment in primary CNS lymphoma

Nashif Chowdhury, Jenni Niemi, Haris Babačić, Hanna‐Maija Rantakylö, Ingrid Glimelius, Mats Jerkeman, Mats Hellström

Open source

DOI
10.1002/hem3.70445
Published
2026-08
Container
HemaSphere
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70445,
  title = {No association between temozolomide maintenance and survival after first‐line treatment in primary CNS lymphoma},
  author = {Nashif Chowdhury and Jenni Niemi and Haris Babačić and Hanna‐Maija Rantakylö and Ingrid Glimelius and Mats Jerkeman and Mats Hellström},
  year = {2026},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70445},
  url = {https://doi.org/10.1002/hem3.70445}
}

RIS

TY  - JOUR
TI  - No association between temozolomide maintenance and survival after first‐line treatment in primary CNS lymphoma
AU  - Nashif Chowdhury
AU  - Jenni Niemi
AU  - Haris Babačić
AU  - Hanna‐Maija Rantakylö
AU  - Ingrid Glimelius
AU  - Mats Jerkeman
AU  - Mats Hellström
PY  - 2026
JO  - HemaSphere
DO  - 10.1002/hem3.70445
UR  - https://doi.org/10.1002/hem3.70445
ER  - 

APA

Chowdhury, N., Niemi, J., Babačić, H., Rantakylö, H., Glimelius, I., Jerkeman, M., & Hellström, M. (2026). No association between temozolomide maintenance and survival after first‐line treatment in primary CNS lymphoma. HemaSphere. https://doi.org/10.1002/hem3.70445

Source records